Beaker List – Cornell Edition
Top Entrepreneurial Life Science Professors @ Cornell
BIOS: Nucleus of Life Science Innovation 🚀
JOBS
BIOS Talent: Find Jobs @ Breakout TechBio Startups — Search Jobs 🚀
Post Jobs: Add Your Startup to BIOS Talent — Post Now 🎉
Students: Join Alix Ventures Fellowship — Join Now 🧬
BIOS Contributor: Share Your Thought Leadership — Join Now🔬
CONTENT & COMMUNITY
BIOS Daily: Join 25K+ Subscribers Following TechBio — Sign Up 🔥
BIOS Insider: Premium TechBio Thought Leadership — Sign Up ✨
BIOS Commons: World’s Largest #TechBio Community — Join Now 🎉
INVEST
BIOS Angels: 1st TechBio Angel Investing Syndicate — Join Now 🌟
Alix Limited: Invest in Breakout TechBio Startups — Learn More 🧠
By:
Alix Ventures: Supporting Early Stage Life Science Startups Engineering Biology to Drive Radical Advances in Human Health
Overview
Behind every transformative technology is a team of brilliant scientists and researchers. Academic research in particular is a driving force for technological innovation. Here, we have identified a ‘Midas List’ of researchers who have pioneered highly transformative technologies that have translated to the clinic. Using venture backed startups as a primary guide along with other impact metrics such as patents, citations, and thought leadership, the following professors have demonstrated patient impact, providing significant contributions to the startup ecosystem.
Cornell University is ranked 12th on average over the past 30 years by the U.S. News & World Report National Universities ranking and holds a strong reputation as a top tier research organization. As of September 2021, 61 Nobel laureates, four Turing Award winners and one Fields Medalist have been affiliated with Cornell. Among its notable achievements, spanning some of the first therapeutic interventions for hemolytic diseases in infants to bioregenerative medicine, Cornell currently spends over $1.19 billion annually on research. A keystone of this research expenditure is dedicated to the Weill Cornell Medicine (WCM). Located at the heart of New York City’s Upper East Side Medical Research Corridor, the WCM is committed to eradicating disease and enhancing human health through cutting-edge, translational science. With expertise spanning the spectrum of disciplines, WCM scientists target some of the most formidable health challenges of the 21st century, including cancer, cardiovascular disease, metabolic diseases, neurodegenerative diseases such as Parkinson’s and Alzheimer’s, diseases affecting children, and infectious diseases, especially those with significant impact on the developing world. Weill Cornell Medicine’s Centers and Institutes lead cross-disciplinary biomedical research efforts to improve patient care and are pushing scientific discoveries forward through employing precision medicine and other advanced research methods to unearth the molecular underpinnings of disease with hopes of quickly applying laboratory breakthroughs to the clinic. With collaborators at seven affiliated hospitals and research institutes, WCM’s high-impact research seeks to unlock the mysteries of the human body and alleviate suffering caused by disease. As an example of the amazing work that this university is producing, we would like to highlight ten professors leading life science entrepreneurship efforts at Cornell, both in innovation and strengthening the entrepreneurial ecosystem of the school.
Chris Mason
Chris Mason is a professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine. He is a systems thinker, who frequently characterizes multi-omic data in a variety of environments—from cruise ships to Chernobyl-struck villages to outer space. Chris works with NASA to design the metagenome for life in space and is a proud contributor to the 500 Year Plan, a long-term survival plan for Earth’s inhabitants. The Mason lab currently develops and deploys new biochemical and computational methods in functional genomics, and metagenomics. The group also works closely with NIST/FDA to build international standards. These methods are also being integrated for longitudinal multi-omic profiling of NASA astronauts and for genetic and epigenetic diagnostics on the International Space Station.
Mason currently holds 59 patents and has co-founded four biotechnology startup companies including Onegevity Health, Biotia, BridgeOmics, & Genome Liberty.
Learn more about Chris Mason’s work on BIOS Frontier Science: Listen Now